The Valley Desk

NCT01217203 · Interventional trial

Study on the Safety, Anti-tumor Activity and Pharmacology of IPH2101 Combined With Lenalidomide in Patients With Multiple Myeloma Experiencing a First or Second Relapse

Overall registry status Completed

Phase 1

Conditions First or Second Relapse, Patients With Multiple Myeloma Experiencing a

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov